Authors: Brian J Linder Emanuel C Trabuco Daniel A Carranza John B Gebhart Christopher J Klingele John A Occhino
Publish Date: 2016/02/10
Volume: 27, Issue: 9, Pages: 1333-1336
Abstract
We identified female patients undergoing implantation of mesh materials for stress urinary incontinence at our institution from 1 January 2002 to 31 December 2012 This was accomplished by querying the medical records for CPT code 57288 “sling operation for stress incontinence” and a subsequent chart review to identify patients who underwent synthetic mesh sling placement Medical records were then evaluated for the documentation of bladder urethral vaginal cervical uterine or ovarian cancers via the International Classification of Disease ninth edition coding A chart review of patients with a cancer diagnosis was performed for verification of the diagnosis and evaluation of the temporal relationship with sling placementDuring the study period 2474 patients underwent polypropylene midurethral sling placement The median age was 57 years IQR 47 69 and the median followup was 60 months IQR 233 949 Overall 51 patients also had a cancer diagnosis 8 bladder cancers 7 vaginal malignancies 8 ovarian carcinomas 26 endometrial cancers 2 cervical malignancies however only 2 cancers 008 2 out of 2474 developed following sling placement a vaginal melanoma 3 years after sling placement and an ovarian tumor 1 year after sling placement No cases of sarcoma formation bladder urethral or squamous cell carcinomas were identified
Keywords: